A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

November 1, 2010

Primary Completion Date

April 25, 2011

Study Completion Date

April 25, 2011

Conditions

Healthy

Interventions

DRUG

PF-03382792 0.5mg

0.5 mg PF-03382792, qd, for 14 days or placebo

DRUG

PF-03382792 1.5 mg

1.5 mg PF-03382792, qd, for 14 days or placebo

DRUG

PF-03382792 5 mg

5 mg PF-03382792, qd, for 14 days or placebo

DRUG

PF-03382792 15 mg

15 mg PF-03382792, qd, for 14 days or placebo